2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors
US-9428508-B2 · Aug 30, 2016 · US
Centaurus Biopharma Co Ltd was listed as an assignee on 3 patent publications in 2016.
| Metric | Value |
|---|---|
| Company | Centaurus Biopharma Co Ltd |
| Year | 2016 |
| Patents | 3 |
Representative publications for Centaurus Biopharma Co Ltd in 2016.
US-9428508-B2 · Aug 30, 2016 · US
US-2016214964-A1 · Jul 28, 2016 · US
US-2016002205-A1 · Jan 7, 2016 · US
Most common classification codes for Centaurus Biopharma Co Ltd in 2016.
| CPC | Patents |
|---|---|
| A61P35/00 | 3 |
| A61K31/5377 | 2 |
| A61P43/00 | 2 |
| C07D401/12 | 2 |
| C07D401/14 | 2 |
Navigate to parent entity pages.